Legend Biotechcorp Stock Buy Hold or Sell Recommendation

LEGN Stock  USD 65.53  0.37  0.57%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Legend BiotechCorp is 'Strong Sell'. Macroaxis provides Legend BiotechCorp buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LEGN positions. The advice algorithm takes into account all of Legend BiotechCorp's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Osisko Gold Ro's buy or sell advice are summarized below:
Real Value
71.08
Target Price
88.36
Hype Value
65.59
Market Value
65.53
Naive Value
68.48
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Legend BiotechCorp given historical horizon and risk tolerance towards Legend BiotechCorp. When Macroaxis issues a 'buy' or 'sell' recommendation for Legend BiotechCorp, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Legend BiotechCorp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.
In addition, we conduct extensive research on individual companies such as Legend and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Legend BiotechCorp. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Execute Legend BiotechCorp Buy or Sell Advice

The Legend recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Legend BiotechCorp. Macroaxis does not own or have any residual interests in Legend BiotechCorp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Legend BiotechCorp's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Legend BiotechCorpBuy Legend BiotechCorp
Strong Sell

Market Performance

InsignificantDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Barely shadows the marketDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Legend BiotechCorp has a Mean Deviation of 1.95, Semi Deviation of 1.88, Standard Deviation of 2.53, Variance of 6.43, Downside Variance of 3.87 and Semi Variance of 3.55
Macroaxis provides unbiased advice on Legend BiotechCorp that should be used to complement current analysts and expert consensus on Legend BiotechCorp. Our investment recommendation engine determines the firm's potential to grow exclusively from the perspective of an investors' current risk tolerance and investing horizon. To make sure Legend BiotechCorp is not overpriced, please verify all Legend BiotechCorp fundamentals, including its shares owned by institutions, cash and equivalents, earnings per share, as well as the relationship between the revenue and current ratio . Given that Legend BiotechCorp has a number of shares shorted of 9.94 M, we recommend you to check Legend BiotechCorp market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Legend BiotechCorp Trading Alerts and Improvement Suggestions

The company reported the previous year's revenue of 233.31 M. Net Loss for the year was (509.31 M) with loss before overhead, payroll, taxes, and interest of (284.01 M).
Legend BiotechCorp currently holds about 791.26 M in cash with (347.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11.
Legend BiotechCorp has a poor financial position based on the latest SEC disclosures
Latest headline from news.google.com: Legend Biotech Reports First Quarter 2022 Financial Results and Recent Highlights - The Globe and Mail

Legend BiotechCorp Returns Distribution Density

The distribution of Legend BiotechCorp's historical returns is an attempt to chart the uncertainty of Legend BiotechCorp's future price movements. The chart of the probability distribution of Legend BiotechCorp stock daily returns describes the distribution of returns around its average expected value. We use Legend BiotechCorp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Legend BiotechCorp returns is essential to provide solid investment advice for Legend BiotechCorp.
Mean Return
0.13
Value At Risk
-3.28
Potential Upside
4.46
Standard Deviation
2.53
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Legend BiotechCorp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Legend Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Legend BiotechCorp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Legend BiotechCorp backward and forwards among themselves. Legend BiotechCorp's institutional investor refers to the entity that pools money to purchase Legend BiotechCorp's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Federated Hermes Inc2023-12-31
1.7 M
Adage Capital Partners Gp Llc2023-09-30
1.7 M
Westfield Capital Management Company, Lp2023-09-30
1.7 M
Wellington Management Company Llp2023-09-30
1.3 M
Holocene Advisors, Lp2023-09-30
1.3 M
Alliancebernstein L.p.2023-09-30
1.1 M
Arrowmark Colorado Holdings, Llc (arrowmark Partners)2023-09-30
1.1 M
Timessquare Capital Management, Llc2023-12-31
1.1 M
Avidity Partners Management Lp2023-09-30
967 K
Fmr Inc2023-09-30
15.9 M
T. Rowe Price Associates, Inc.2023-09-30
9.7 M
Note, although Legend BiotechCorp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Legend BiotechCorp Cash Flow Accounts

201920202021202220232024 (projected)
Capital Expenditure(26.7M)(26.3M)(42.2M)(20.9M)(18.8M)(20.3M)
Depreciation Amortization and Accretion5.3M9.9M13.9M18.4M21.2M16.8M
Net Cash Flow or Change in Cash and Cash Equivalents(127.1M)371.7M233.2M99.6M114.5M151.2M
Net Cash Flow Business Acquisitions and Disposals38.1M(19.5M)(1.7M)(14.8M)(17.0M)(18.4M)
Issuance Repayment of Debt Securities14.7M(2.6M)(1.4M)(2.6M)(2.3M)(2.4M)
Net Cash Flow from Financing14.7M618.9M626.7M378.0M434.7M418.7M
Net Cash Flow from Investing(58.7M)(24.2M)(195.0M)(77.1M)(69.4M)(74.9M)
Net Cash Flow Investment Acquisitions and Disposals(69.5M)25.6M(147.9M)(40.0M)(36.0M)(38.8M)
Net Cash Flow from Operations(76.4M)(233.3M)(199.5M)(210.0M)(189.0M)(194.0M)
Effect of Exchange Rate Changes on Cash249K620K34K(2.5M)(2.3M)(2.3M)
Share Based Compensation1.3M4.8M20.2M34.3M39.5M42.6M

Legend BiotechCorp Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Legend BiotechCorp or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Legend BiotechCorp's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Legend stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
0.1
β
Beta against NYSE Composite0.12
σ
Overall volatility
2.52
Ir
Information ratio -0.01

Legend BiotechCorp Volatility Alert

Legend BiotechCorp has relatively low volatility with skewness of 0.85 and kurtosis of 1.02. However, we advise all investors to independently investigate Legend BiotechCorp to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Legend BiotechCorp's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Legend BiotechCorp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Legend BiotechCorp Fundamentals Vs Peers

Comparing Legend BiotechCorp's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Legend BiotechCorp's direct or indirect competition across all of the common fundamentals between Legend BiotechCorp and the related equities. This way, we can detect undervalued stocks with similar characteristics as Legend BiotechCorp or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Legend BiotechCorp's fundamental indicators could also be used in its relative valuation, which is a method of valuing Legend BiotechCorp by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Legend BiotechCorp to competition
FundamentalsLegend BiotechCorpPeer Average
Return On Equity-0.49-0.31
Return On Asset-0.18-0.14
Profit Margin(2.18) %(1.27) %
Operating Margin(0.96) %(5.51) %
Current Valuation10.84 B16.62 B
Shares Outstanding182.29 M571.82 M
Shares Owned By Insiders1.29 %10.09 %
Shares Owned By Institutions48.60 %39.21 %
Number Of Shares Shorted9.94 M4.71 M
Price To Book8.91 X9.51 X
Price To Sales51.20 X11.42 X
Revenue233.31 M9.43 B
Gross Profit(284.01 M)27.38 B
EBITDA(439.3 M)3.9 B
Net Income(509.31 M)570.98 M
Cash And Equivalents791.26 M2.7 B
Cash Per Share5.11 X5.01 X
Total Debt284.53 M5.32 B
Debt To Equity0.29 %48.70 %
Current Ratio3.83 X2.16 X
Book Value Per Share7.37 X1.93 K
Cash Flow From Operations(347.37 M)971.22 M
Short Ratio10.06 X4.00 X
Earnings Per Share(2.96) X3.12 X
Target Price86.29
Number Of Employees1.7 K18.84 K
Beta-0.021-0.15
Market Capitalization11.95 B19.03 B
Total Asset1.33 B29.47 B
Retained Earnings(966.46 M)9.33 B
Working Capital801.33 M1.48 B
Z Score23.988.72
Net Asset1.33 B

Legend BiotechCorp Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Legend . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Legend BiotechCorp Buy or Sell Advice

When is the right time to buy or sell Legend BiotechCorp? Buying financial instruments such as Legend Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Current Assets949.9M1.1B1.3B1.0B
Total Assets1.1B1.3B1.5B1.3B

Use Investing Ideas to Build Portfolios

In addition to having Legend BiotechCorp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Realty Funds Thematic Idea Now

Realty Funds
Realty Funds Theme
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Legend BiotechCorp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend BiotechCorp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotechcorp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotechcorp Stock:
Check out Legend BiotechCorp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.
Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.96)
Revenue Per Share
1.358
Quarterly Revenue Growth
2.509
Return On Assets
(0.18)
Return On Equity
(0.49)
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.